Variant report

Variant	esv1824602
Chromosome Location	chr4:8270320-8271851
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:48)
CpG islands
(count:549)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:48 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CREB1	chr4:8271379-8271648	A549	lung:	n/a	n/a
2	CTBP2	chr4:8271453-8272043	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr4:8271676-8271729	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr4:8271800-8271950	HUVEC	blood vessel:	n/a	n/a
5	E2F6	chr4:8271303-8272073	H1-hESC	embryonic stem cell:	n/a	chr4:8271452-8271459
6	GABPA	chr4:8271367-8272105	H1-hESC	embryonic stem cell:	n/a	chr4:8271466-8271475
7	GABPA	chr4:8271346-8272113	H1-hESC	embryonic stem cell:	n/a	chr4:8271466-8271475
8	HDAC2	chr4:8271336-8271621	HepG2	liver:	n/a	n/a
9	HEY1	chr4:8271384-8271611	HepG2	liver:	n/a	chr4:8271534-8271549
10	JUND	chr4:8271656-8271928	H1-hESC	embryonic stem cell:	n/a	n/a
11	MAX	chr4:8271229-8272186	NB4	blood:	n/a	n/a
12	MAX	chr4:8271407-8272084	H1-hESC	embryonic stem cell:	n/a	n/a
13	MAX	chr4:8271371-8272136	ECC-1	luminal epithelium:	n/a	n/a
14	MAX	chr4:8271406-8272137	H1-hESC	embryonic stem cell:	n/a	n/a
15	MAZ	chr4:8271084-8272147	IMR90	lung:	n/a	n/a
16	MAZ	chr4:8271378-8271405	HepG2	liver:	n/a	n/a
17	MYC	chr4:8271131-8272169	NB4	blood:	n/a	n/a
18	MYC	chr4:8271845-8272041	H1-hESC	embryonic stem cell:	n/a	n/a
19	MYC	chr4:8271818-8271920	HUVEC	blood vessel:	n/a	n/a
20	POLR2A	chr4:8271410-8271633	A549	lung:	n/a	n/a
21	POLR2A	chr4:8271216-8271857	Gliobla	brain:	n/a	n/a
22	POLR2A	chr4:8271060-8271882	HUVEC	blood vessel:	n/a	n/a
23	POLR2A	chr4:8271080-8271713	HUVEC	blood vessel:	n/a	n/a
24	POLR2A	chr4:8271296-8271714	ECC-1	luminal epithelium:	n/a	n/a
25	POLR2A	chr4:8271370-8271660	A549	lung:	n/a	n/a
26	POLR2A	chr4:8271076-8271849	HUVEC	blood vessel:	n/a	n/a
27	POLR2A	chr4:8271267-8271646	ECC-1	luminal epithelium:	n/a	n/a
28	POLR2A	chr4:8271336-8271684	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr4:8271295-8271710	A549	lung:	n/a	n/a
30	POLR2A	chr4:8271155-8271923	HEK293	kidney:	n/a	n/a
31	POLR2A	chr4:8271308-8271670	ProgFib	skin:	n/a	n/a
32	POLR2A	chr4:8271269-8271763	HepG2	liver:	n/a	n/a
33	POLR2A	chr4:8271177-8271707	IMR90	lung:	n/a	n/a
34	POLR2A	chr4:8271145-8271835	HUVEC	blood vessel:	n/a	n/a
35	POLR2A	chr4:8271413-8271572	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr4:8271294-8271784	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr4:8271352-8271603	A549	lung:	n/a	n/a
38	POLR2A	chr4:8271130-8271787	H1-hESC	embryonic stem cell:	n/a	n/a
39	POLR2A	chr4:8271413-8271617	A549	lung:	n/a	n/a
40	POLR2A	chr4:8271404-8271636	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr4:8271106-8272177	NB4	blood:	n/a	n/a
42	RFX5	chr4:8271611-8271622	HepG2	liver:	n/a	n/a
43	SIN3A	chr4:8271549-8271950	H1-hESC	embryonic stem cell:	n/a	n/a
44	TAF1	chr4:8271273-8271624	ECC-1	luminal epithelium:	n/a	n/a
45	TBP	chr4:8271327-8271885	H1-hESC	embryonic stem cell:	n/a	n/a
46	YY1	chr4:8271504-8271806	HepG2	liver:	n/a	n/a
47	YY1	chr4:8271327-8271894	H1-hESC	embryonic stem cell:	n/a	chr4:8271398-8271407 chr4:8271422-8271436
48	ZNF143	chr4:8271362-8271547	H1-hESC	embryonic stem cell:	n/a	chr4:8271465-8271475

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:8270795-8270845	MCF-7	breast:	n/a
2	chr4:8271196-8271246	ProgFib	skin:	n/a
3	chr4:8271792-8271842	Hepatocyte	liver:	n/a
4	chr4:8271319-8271369	AG09319	gingival:	n/a
5	chr4:8271369-8271419	CMK	blood:	n/a
6	chr4:8271369-8271419	HCT-116	colon:	n/a
7	chr4:8271369-8271419	AG10803	skin:	n/a
8	chr4:8271369-8271419	PrEC	prostate:	n/a
9	chr4:8271792-8271842	Jurkat	blood:	n/a
10	chr4:8271196-8271246	SKMC	muscle:	n/a
11	chr4:8271792-8271842	GM06990	blood:	n/a
12	chr4:8271319-8271369	NHBE	bronchial:	n/a
13	chr4:8271369-8271419	GM12891	blood:	n/a
14	chr4:8271319-8271369	HCT-116	colon:	n/a
15	chr4:8270795-8270845	T-47D	breast:	n/a
16	chr4:8270795-8270845	HEEpiC	esophagus:	n/a
17	chr4:8271391-8271441	AG09319	gingival:	n/a
18	chr4:8271414-8271464	GM12892	blood:	n/a
19	chr4:8271369-8271419	GM12892	blood:	n/a
20	chr4:8271236-8271286	HRCEpiC	kidney:	n/a
21	chr4:8271236-8271286	A549	lung:	n/a
22	chr4:8271792-8271842	HCF	heart:	n/a
23	chr4:8271319-8271369	K562	blood:	n/a
24	chr4:8271391-8271441	HCF	heart:	n/a
25	chr4:8270795-8270845	BJ	skin:	n/a
26	chr4:8271196-8271246	HPAEpiC	pulmonary alveolar:	n/a
27	chr4:8271319-8271369	GM06990	blood:	n/a
28	chr4:8271369-8271419	Hepatocyte	liver:	n/a
29	chr4:8271319-8271369	AoSMC	blood vessel:	n/a
30	chr4:8270795-8270845	H1-hESC	embryonic stem cell:	embryo
31	chr4:8271414-8271464	HEEpiC	esophagus:	n/a
32	chr4:8271236-8271286	MCF10A-Er-Src	breast:	n/a
33	chr4:8271507-8271557	HPAEpiC	pulmonary alveolar:	n/a
34	chr4:8270795-8270845	HL-60	blood:	n/a
35	chr4:8271792-8271842	AG09319	gingival:	n/a
36	chr4:8271196-8271246	NB4	blood:	n/a
37	chr4:8271792-8271842	HEEpiC	esophagus:	n/a
38	chr4:8271236-8271286	HEK293	kidney:	embryo
39	chr4:8271319-8271369	PrEC	prostate:	n/a
40	chr4:8271369-8271419	HRCEpiC	kidney:	n/a
41	chr4:8270795-8270845	GM12891	blood:	n/a
42	chr4:8271792-8271842	HCM	heart:	n/a
43	chr4:8271369-8271419	MCF10A-Er-Src	breast:	n/a
44	chr4:8271319-8271369	PANC-1	pancreas:	n/a
45	chr4:8271792-8271842	MCF10A-Er-Src	breast:	n/a
46	chr4:8271414-8271464	HIPEpiC	eye:	n/a
47	chr4:8271236-8271286	SAEC	small airway:	n/a
48	chr4:8270795-8270845	SKMC	muscle:	n/a
49	chr4:8270795-8270845	ProgFib	skin:	n/a
50	chr4:8271391-8271441	RPTEC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:8261913..8264810-chr4:8267913..8270603,2	K562	blood:
2	chr4:8271372..8272005-chr5:137514142..137514696,2	NB4	blood:
3	chr16:28834863..28835527-chr4:8271061..8271579,2	NB4	blood:
4	chr4:8268685..8271204-chr4:8420095..8422355,2	MCF-7	breast:
5	chr3:128902200..128903075-chr4:8271389..8271937,2	NB4	blood:
6	chr10:105156345..105156947-chr4:8271069..8272007,2	NB4	blood:
7	chr4:8271058..8271580-chr5:74632260..74632932,2	NB4	blood:
8	chr4:8268867..8271118-chr4:8273119..8275755,2	MCF-7	breast:

No data

Variant related genes	Relation type
HTRA3	TF binding region
HTRA3	CpG island
ENSG00000169714	chromatin interactions
ENSG00000148843	chromatin interactions
ENSG00000247372	chromatin interactions
ENSG00000112983	chromatin interactions
ENSG00000168488	chromatin interactions
ENSG00000112984	chromatin interactions

Extended variants
information (count: 57 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:57 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6833227	chr4:8270320-8270321	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs538374684	chr4:8270345-8270346	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs6833375	chr4:8270346-8270347	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs548127977	chr4:8270354-8270355	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs151059948	chr4:8270369-8270370	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs139731239	chr4:8270399-8270400	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs371690024	chr4:8270467-8270468	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs114109557	chr4:8270472-8270473	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs369560990	chr4:8270482-8270483	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs372200281	chr4:8270533-8270534	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs115117906	chr4:8270541-8270542	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs73081570	chr4:8270554-8270555	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs542536298	chr4:8270569-8270570	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs188988337	chr4:8270607-8270608	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs73224086	chr4:8270628-8270629	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs560782415	chr4:8270670-8270671	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs149798841	chr4:8270671-8270672	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs564508452	chr4:8270687-8270688	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs558021480	chr4:8270831-8270832	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs540763793	chr4:8270856-8270857	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs559283185	chr4:8270890-8270891	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs572571353	chr4:8270910-8270911	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs558996315	chr4:8270915-8270916	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs377734674	chr4:8270930-8270931	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs548066545	chr4:8270941-8270942	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs569577936	chr4:8270962-8270963	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs35526517	chr4:8271010-8271011	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs34978023	chr4:8271022-8271023	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs368933257	chr4:8271030-8271031	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs551836770	chr4:8271033-8271034	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs570433896	chr4:8271087-8271088	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs534410187	chr4:8271167-8271168	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs115950267	chr4:8271188-8271189	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs181048022	chr4:8271219-8271220	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs561563864	chr4:8271247-8271248	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs536024959	chr4:8271251-8271252	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs557611752	chr4:8271287-8271288	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs112506087	chr4:8271291-8271292	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs546529736	chr4:8271294-8271295	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs568979923	chr4:8271300-8271301	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs540181377	chr4:8271313-8271314	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs557860642	chr4:8271315-8271316	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs145693652	chr4:8271327-8271328	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs540350504	chr4:8271340-8271341	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs13138308	chr4:8271428-8271429	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
46	rs562246578	chr4:8271437-8271438	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
47	rs116146438	chr4:8271445-8271446	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
48	rs71603922	chr4:8271481-8271482	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
49	rs184906740	chr4:8271489-8271490	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
50	rs563142059	chr4:8271527-8271528	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	22241247	CNVD
Autosomal-dominant microtia	18179897	CNVD
Glioma	17123091	CNVD
Colorectal cancer	20459617	CNVD
Breast cancer	17133270	CNVD
Sezary syndrome	18413736	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Autism	20841430	CNVD

Chromatin state (count:229 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:8254800-8271600	Weak transcription	Gastric	stomach
2	chr4:8258000-8271000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr4:8263800-8270800	Weak transcription	Lung	lung
4	chr4:8268000-8271200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
5	chr4:8268200-8272200	Enhancers	Fetal Heart	heart
6	chr4:8268400-8270800	Enhancers	Stomach Smooth Muscle	stomach
7	chr4:8268400-8271000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr4:8268800-8270800	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr4:8269200-8270400	Weak transcription	Fetal Lung	lung
10	chr4:8269200-8270800	Enhancers	Primary hematopoietic stem cells short term culture	blood
11	chr4:8269200-8270800	Weak transcription	HUVEC	blood vessel
12	chr4:8269400-8270600	Weak transcription	Primary hematopoietic stem cells	blood
13	chr4:8269400-8270600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr4:8269400-8270800	Weak transcription	Left Ventricle	heart
15	chr4:8269400-8270800	Weak transcription	Ovary	ovary
16	chr4:8269400-8271400	Weak transcription	Right Atrium	heart
17	chr4:8269600-8270600	Weak transcription	Colon Smooth Muscle	Colon
18	chr4:8269600-8270600	Weak transcription	Placenta Amnion	Placenta Amnion
19	chr4:8269600-8270600	Weak transcription	Skeletal Muscle Male	skeletal muscle
20	chr4:8269600-8270800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr4:8269600-8270800	Weak transcription	Right Ventricle	heart
22	chr4:8269600-8271000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr4:8269600-8271000	Weak transcription	Adipose Nuclei	Adipose
24	chr4:8269600-8271600	Weak transcription	Pancreas	Pancrea
25	chr4:8269600-8271800	Weak transcription	A549	lung
26	chr4:8270000-8271000	Weak transcription	Psoas Muscle	Psoas
27	chr4:8270200-8270400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr4:8270200-8271200	Enhancers	Fetal Muscle Leg	muscle
29	chr4:8270200-8271400	Bivalent Enhancer	Placenta	Placenta
30	chr4:8270400-8271000	Enhancers	Fetal Lung	lung
31	chr4:8270400-8271000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
32	chr4:8270600-8270800	Enhancers	K562	blood
33	chr4:8270600-8271000	Enhancers	Primary hematopoietic stem cells	blood
34	chr4:8270600-8271000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr4:8270600-8271000	Bivalent Enhancer	Fetal Stomach	stomach
36	chr4:8270600-8271000	Enhancers	Skeletal Muscle Male	skeletal muscle
37	chr4:8270600-8271200	Bivalent Enhancer	Fetal Kidney	kidney
38	chr4:8270600-8271400	Enhancers	Placenta Amnion	Placenta Amnion
39	chr4:8270600-8271600	Enhancers	Colon Smooth Muscle	Colon
40	chr4:8270600-8272200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
41	chr4:8270800-8271000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
42	chr4:8270800-8271000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr4:8270800-8271000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr4:8270800-8271000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr4:8270800-8271000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr4:8270800-8271000	Enhancers	Right Ventricle	heart
47	chr4:8270800-8271000	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
48	chr4:8270800-8271200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
49	chr4:8270800-8271200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr4:8270800-8271200	Enhancers	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links